At close: December 20 at 4:00:02 PM EST
After hours: December 20 at 7:16:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
175,041.0000
60,281.0000
27,148.0000
6,149.0000
3,958.0000
Operating Expense
220,138.0000
198,319.0000
188,816.0000
168,395.0000
137,363.0000
Operating Income
-45,097.0000
-138,038.0000
-161,668.0000
-162,246.0000
-133,405.0000
Net Non Operating Interest Income Expense
4,778.0000
5,964.0000
1,542.0000
1,095.0000
2,313.0000
Other Income Expense
-2,970.0000
19,539.0000
-2,833.0000
3,852.0000
1,162.0000
Pretax Income
-43,289.0000
-112,535.0000
-162,959.0000
-157,299.0000
-129,930.0000
Tax Provision
1,227.0000
1,336.0000
2,497.0000
791.0000
162.0000
Net Income Common Stockholders
-44,516.0000
-113,871.0000
-165,456.0000
-158,090.0000
-130,092.0000
Diluted NI Available to Com Stockholders
-44,516.0000
-113,871.0000
-165,456.0000
-158,090.0000
-130,092.0000
Basic EPS
-0.17
-0.54
-1.02
-1.02
-0.90
Diluted EPS
-0.17
-0.54
-1.02
-1.02
-0.90
Basic Average Shares
245,170.2050
201,073.4960
161,207.0670
155,805.5030
142,463.9600
Diluted Average Shares
248,977.2730
201,073.4960
161,207.0670
155,805.5030
142,463.9600
Total Operating Income as Reported
-45,097.0000
-139,741.0000
-163,965.0000
-162,246.0000
-133,405.0000
Total Expenses
220,138.0000
198,319.0000
188,816.0000
168,395.0000
137,363.0000
Net Income from Continuing & Discontinued Operation
-44,516.0000
-113,871.0000
-165,456.0000
-158,090.0000
-130,092.0000
Normalized Income
-44,516.0000
-130,351.2600
-163,595.4300
-158,090.0000
-130,092.0000
Interest Income
6,413.0000
5,964.0000
1,542.0000
1,095.0000
2,313.0000
Net Interest Income
4,778.0000
5,964.0000
1,542.0000
1,095.0000
2,313.0000
EBIT
-67,157.0000
-138,038.0000
-161,668.0000
-162,246.0000
-133,405.0000
EBITDA
-55,896.0000
-128,198.0000
-155,593.0000
-155,679.0000
-125,811.0000
Reconciled Depreciation
11,261.0000
9,840.0000
6,075.0000
6,567.0000
7,594.0000
Net Income from Continuing Operation Net Minority Interest
-44,516.0000
-113,871.0000
-165,456.0000
-158,090.0000
-130,092.0000
Total Unusual Items Excluding Goodwill
--
20,346.0000
-2,297.0000
--
--
Total Unusual Items
--
20,346.0000
-2,297.0000
--
--
Normalized EBITDA
-55,896.0000
-148,544.0000
-153,296.0000
-155,679.0000
-125,811.0000
Tax Rate for Calcs
0.0003
0.0002
0.0002
0.0002
--
Tax Effect of Unusual Items
--
3,865.7400
-436.4300
--
--
12/31/2020 - 5/6/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AFMD Affimed N.V.
1.1900
+0.85%
ADCT ADC Therapeutics SA
1.9600
-7.55%
NKTX Nkarta, Inc.
2.3700
+7.73%
IMTX Immatics N.V.
6.85
-0.44%
SGMO Sangamo Therapeutics, Inc.
2.4700
+6.93%
IMCR Immunocore Holdings plc
28.33
-0.33%
LXRX Lexicon Pharmaceuticals, Inc.
0.7147
-1.23%
ATRA Atara Biotherapeutics, Inc.
11.40
+14.80%
CTMX CytomX Therapeutics, Inc.
1.0900
-0.91%
GLPG Galapagos NV
26.76
+1.48%